UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

Osteosarcoma of the jaws: An overview of the pathophysiological mechanisms

Critical reviews in oncology/hematology, 2020-12, Vol.156, p.103126-103126, Article 103126

2020

Volltextzugriff (PDF)

RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases

Cellular and molecular life sciences : CMLS, 2007-09, Vol.64 (18), p.2334-2350

2007

Volltextzugriff (PDF)

Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B

The Journal of pathology, 2007-04, Vol.211 (5), p.555-562

2007

Volltextzugriff (PDF)

Zoledronic Acid Activates the DNA S-Phase Checkpoint and Induces Osteosarcoma Cell Death Characterized by Apoptosis-Inducing Factor and Endonuclease-G Translocation Independently of p53 and Retinoblastoma Status

Molecular pharmacology, 2007-01, Vol.71 (1), p.333-343

2007

Volltextzugriff (PDF)

Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53

Oncogene, 2007-10, Vol.26 (46), p.6653-6664

2007

Volltextzugriff (PDF)

The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets

Sarcoma, 2011, Vol.2011, p.932451-8

2011

Volltextzugriff (PDF)

Therapeutic approach of primary bone tumours by bisphosphonates

Current pharmaceutical design, 2010-01, Vol.16 (27), p.2981

2010

Volltextzugriff (PDF)

RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis

BBA - Reviews on Cancer, 2004-09, Vol.1704 (2), p.49-57

2004

Volltextzugriff (PDF)

Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models

Cancer gene therapy, 2010-06, Vol.17 (6), p.387-397

2010

Volltextzugriff (PDF)

Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma

Bone (New York, N.Y.), 2005-07, Vol.37 (1), p.74-86

2005

Volltextzugriff (PDF)

Serglycin: the master of the mast cell

Methods in molecular biology (Clifton, N.J.), 2012, Vol.836, p.201

2012

Volltextzugriff (PDF)

Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANK

Biochemical and biophysical research communications, 2006-08, Vol.347 (2), p.460-467

2006

Volltextzugriff (PDF)

Transcriptional inhibition of connexin 43 BY EWS-FLI1: Implication in tumor development of ewing's sarcoma

Bone (New York, N.Y.), 2012-05, Vol.50, p.S50-S50

2012

Volltextzugriff (PDF)

Glycosaminoglycan chain analysis and characterization (glycosylation/epimerization)

Methods in molecular biology (Clifton, N.J.), 2012-01, Vol.836, p.99

2012

Volltextzugriff (PDF)

Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma

BMC cancer, 2005-09, Vol.5 (1), p.123-123, Article 123

2005

Volltextzugriff (PDF)

DU145 human prostate cancer cells express functional receptor activator of NFκB: New insights in the prostate cancer bone metastasis process

Bone (New York, N.Y.), 2007-04, Vol.40 (4), p.981-990

2007

Volltextzugriff (PDF)

Oncostatin M is a growth factor for ewing sarcoma: Potent role of the leukemia inhibitory factor receptor

Bone (New York, N.Y.), 2011-05, Vol.48, p.S254-S254

2011

Volltextzugriff (PDF)

Impact of onco-pediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient

Bone (New York, N.Y.), 2011-05, Vol.48, p.S248-S248

2011

Volltextzugriff (PDF)

Oncostatin M leads to opposite effects on the proliferation of different primary bone tumors

Bone (New York, N.Y.), 2010-06, Vol.47, p.S108-S109

2010

Volltextzugriff (PDF)

Shedding of cell membrane-bound proteoglycans

Methods in molecular biology (Clifton, N.J.), 2012, Vol.836, p.291

2012

Volltextzugriff (PDF)

Regulation of osteoclast protease expression by RANKL

Biochemical and biophysical research communications, 2003-10, Vol.310 (3), p.774-778

2003

Volltextzugriff (PDF)

Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on Oncostatin M signaling

Bone (New York, N.Y.), 2012-05, Vol.50, p.S83-S83

2012

Volltextzugriff (PDF)

Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on Oncostatin M signaling

Bone (New York, N.Y.), 2012-05, Vol.50, p.S67-S67

2012

Volltextzugriff (PDF)

Brain chondroitin/dermatan sulfate, from cerebral tissue to fine structure: extraction, preparation, and fully automated chip-electrospray mass spectrometric analysis

Methods in molecular biology (Clifton, N.J.), 2012-01, Vol.836, p.145

2012

Volltextzugriff (PDF)

Trail sensitivity in Ewing's sarcoma patients is modulated by the expression of death receptor 4 and its short isoform despite predominant dr5 level

Bone (New York, N.Y.), 2011-05, Vol.48, p.S255-S255

2011

Volltextzugriff (PDF)

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(88)
Animals
(72)
Humans
(58)
Biochemistry & Molecular Biology
(43)
Biological And Medical Sciences
(34)
Orthopedics
(29)
Life Sciences
(28)
Mice
(27)
Cells, Cultured
(26)
Biochemical Research Methods
(22)
Male
(22)
Rabbits
(22)
Fundamental And Applied Biological Sciences. Psychology
(21)
Oncology
(21)
Cell Biology
(19)
Rats
(18)
Medical Sciences
(16)
Osteosarcoma
(14)
Proteoglycans - Metabolism
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Osteosarcoma of the jaws: An overview of the pathophysiological mechanisms

RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases

Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B

Zoledronic Acid Activates the DNA S-Phase Checkpoint and Induces Osteosarcoma Cell Death Characterized by Apoptosis-Inducing Factor and Endonuclease-G Translocation Independently of p53 and Retinoblastoma Status

Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53

The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets

Therapeutic approach of primary bone tumours by bisphosphonates

RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis

Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models

Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma

Serglycin: the master of the mast cell

Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANK

Transcriptional inhibition of connexin 43 BY EWS-FLI1: Implication in tumor development of ewing's sarcoma

Glycosaminoglycan chain analysis and characterization (glycosylation/epimerization)

Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma

DU145 human prostate cancer cells express functional receptor activator of NFκB: New insights in the prostate cancer bone metastasis process

Oncostatin M is a growth factor for ewing sarcoma: Potent role of the leukemia inhibitory factor receptor

Impact of onco-pediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient

Oncostatin M leads to opposite effects on the proliferation of different primary bone tumors

Shedding of cell membrane-bound proteoglycans

Regulation of osteoclast protease expression by RANKL

Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on Oncostatin M signaling

Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on Oncostatin M signaling

Brain chondroitin/dermatan sulfate, from cerebral tissue to fine structure: extraction, preparation, and fully automated chip-electrospray mass spectrometric analysis

Trail sensitivity in Ewing's sarcoma patients is modulated by the expression of death receptor 4 and its short isoform despite predominant dr5 level

Suchergebnisse filtern